# PGx Medication Safety Reviews of Persons With IDD

> **NCT07092852** · — · NOT_YET_RECRUITING · sponsor: **GalenusRx, Inc.** · enrollment: 700 (estimated)

## Conditions studied

- Intellectual Disability, Mild
- Intellectual Disability, Mild to Moderate
- Developmental Disability

## Interventions

- **OTHER:** Cheek swab for PGx testing
- **OTHER:** Medication safety review

## Key facts

- **NCT ID:** NCT07092852
- **Lead sponsor:** GalenusRx, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-08-01
- **Primary completion:** 2027-07-31
- **Final completion:** 2028-01-31
- **Target enrollment:** 700 (ESTIMATED)
- **Last updated:** 2025-07-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07092852

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07092852, "PGx Medication Safety Reviews of Persons With IDD". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT07092852. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*